News for Medtronic plc (2M6.DE)

PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial

We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks...

Summary On March 9, 2025, Medtronic PLC (MDT), a leader in healthcare technology, released the two-year results of the SMART Trial, the largest international he

PR NewswireGALWAY, Ireland and WASHINGTON, March 9, 2025 CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to prim

Dividend stocks have been overshadowed in the market as tech and AI-related equities have surged to record levels.

PR NewswireBOSTON, March 3, 2025 Frank Chan joins Haemonetics as Executive Vice President, Chief Operating Officer; Roy Galvin named Executive Vice Preside

Summary Medtronic PLC (MDT), a global leader in healthcare technology, announced the launch of Medtronic Spark on March 3, 2025. This 10-year initiative aims to

Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not deliver a repeat performance.

Medtronic PLC exhibits robust financial performance with increased net sales and operating profit.Strategic positioning in the medical devices sector with a di

Masimo Corp's robust healthcare segment continues to drive significant revenue, showcasing the company's strong market presence.Technological innovation and pr

Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corporation (SCHW), Gilead Sciences, Inc. (GILD) and Medtronic plc (MDT), as well as two micro-cap stocks Cooper-Standard Holdings Inc. (CPS) and Rave Restaurant Group, Inc. (RAVE).

On February 24, 2025, Medtronic PLC (MDT), a leader in healthcare technology, announced the U.S. FDA approval of its BrainSenseâ„¢ Adaptive deep brain stimulati

PR NewswireGALWAY, Ireland, Feb. 24, 2025 New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial

Revenue: $8.3 billion, 4.1% organic growth.Adjusted EPS: $1.39, up 6.9%.Cardiac Ablation Solutions Growth: 22% growth.Leadless Pacing Growth: 24% growth.Neurom

Feb 18, 2025 / 01:00PM GMTRyan Weispfenning - Medtronic PLC - Head of Investor Relations, Vice President Good morning. I'm Ryan Weispfenning, Vice President and

Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.

Medtronic plc (NYSE:MDT) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ETCompany ParticipantsRyan Weispfenning - Vice President and Head of...

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation

The following slide deck was published by Medtronic plc in conjunction with their 2025 Q3 earnings call.